A US draft policy from the Department of Health and Human Services (HHS) names six peptides. This page sets out what each is as a molecule and what the policy documents say about the evidence. It does not alter UK rules, which are covered in is BPC-157 legal in the UK.

What is each of the six peptides?

PeptideWhat it is
BPC-157Synthetic 15-amino-acid peptide derived from a gastric protein sequence
TB-500Synthetic 7-amino-acid fragment of thymosin beta-4 (Ac-LKKTETQ)
MOTS-c16-amino-acid peptide encoded in mitochondrial DNA
KPVLys-Pro-Val, a three-amino-acid fragment of alpha-melanocyte-stimulating hormone
SemaxSynthetic heptapeptide analogue of an ACTH fragment, with a Pro-Gly-Pro tail
EpitalonSynthetic tetrapeptide (Ala-Glu-Asp-Gly)

TB-500 is a short fragment, not thymosin beta-4 itself, which is a 43-amino-acid protein.

What did HHS say about the evidence?

HHS described FDA scientists' concerns about TB-500, Epitalon and Semax as "inferential or mechanistic rather than observed", and for KPV as reflecting "an absence of information". FDA briefing materials called the BPC-157 studies limited in size and duration, without establishing safety or effectiveness.

EPS documentation

Use the research catalogue to check the exact name, labelled amount and format. The COA library publishes the original Janoshik reports selected for EPS, retaining the original report client name and any missing batch fields. Literature findings and another supplier's analytical results are not evidence about an EPS batch.